Force majeure: therapeutic measures in response to restricted supply of imiglucerase (Cerezyme) for patients with Gaucher disease. [electronic resource]
Producer: 20100503Description: 41-7 p. digitalISSN:- 1096-0961
- 1-Deoxynojirimycin -- analogs & derivatives
- Africa, Northern -- epidemiology
- Compassionate Use Trials
- Drug Contamination -- prevention & control
- Drugs, Investigational -- supply & distribution
- Enzyme Inhibitors -- therapeutic use
- Enzyme Replacement Therapy -- statistics & numerical data
- Equipment Contamination
- Europe -- epidemiology
- Gaucher Disease -- drug therapy
- Glucosylceramidase -- supply & distribution
- Guidelines as Topic
- Health Care Rationing
- Health Priorities
- Humans
- International Cooperation
- Middle East -- epidemiology
- Recombinant Proteins -- supply & distribution
- Vesivirus
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.